Financhill
Back

Monopar Therapeutics Stock Predictions

Monopar Therapeutics Stock Forecast

  • Is Monopar Therapeutics Stock Undervalued?
    The current Monopar Therapeutics [MNPR] share price is $0.76. The Score for MNPR is 63, which is 26% above its historic median score of 50, and infers lower risk than normal.
  • MNPR is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.

Will Monopar Therapeutics Stock Go Up Next Year?

Data Unavailable

Monopar Therapeutics Stock Rating

Data Unavailable

Monopar Therapeutics Stock Price History

Is MNPR stock going to rise?

  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and MNPR is experiencing slight buying pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
monopartx.com

52-Week Data

52-Week High:
1.75
52-Week Low:
0.27

Prediction Charts

Market Cap:
13.22M
Price in USD:
0.76
Volume:
81.02K
Beta:
1.19

Technical Analysis

SMA50:
0.76
SMA100:
0.58
SMA200:
0.56
52-Wk Change:
-23.59%

Stock Predictions

  • Is Monopar Therapeutics stock public?
    Yes, Monopar Therapeutics is a publicly traded company.
  • What is the Monopar Therapeutics stock quote today?
    The Monopar Therapeutics stock price is 0.76 USD today.
  • How to buy Monopar Therapeutics stock online?
    You can buy Monopar Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Apr-17 0.69 0.66 0.72 0.65
Apr-18 0.70 0.68 0.72 0.66
Apr-19 0.68 0.64 0.68 0.62
Apr-22 0.66 0.63 0.66 0.62
Apr-23 0.62 0.65 0.66 0.61
Apr-24 0.68 0.66 0.68 0.63
Apr-25 0.65 0.63 0.65 0.62
Apr-26 0.63 0.66 0.67 0.63
Apr-29 0.68 0.65 0.68 0.64
Apr-30 0.63 0.66 0.69 0.63
May-1 0.65 0.65 0.68 0.64
May-2 0.64 0.66 0.67 0.64
May-3 0.67 0.73 0.76 0.64
May-6 0.72 0.76 0.80 0.70

Monopar Therapeutics Earnings

Data Unavailable

Monopar Therapeutics Forecast Revenue Growth

Data Unavailable

  • Analysts estimate an earnings decrease this quarter of $0.03 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.07 per share, and an increase next year of $0.12 per share.

* Monopar Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.